Your browser doesn't support javascript.
loading
Development of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.
Pero, Stephanie C; Nagulapally, Abhinav B; Mei, Linda; Zhang, Fan; Sholler, Giselle S; Krag, David N; Shukla, Girja S.
Afiliación
  • Pero SC; Department of Surgery and University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT.
  • Nagulapally AB; Department of Pediatric Hematology and Oncology, Levine Cancer Institute/Atrium Health Children's Hospital, Charlotte, NC.
  • Mei L; Department of Surgery and University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT.
  • Zhang F; The Vermont Biomedical Research Network, University of Vermont, Burlington, VT, USA.
  • Sholler GS; Department of Pediatric Hematology and Oncology, Levine Cancer Institute/Atrium Health Children's Hospital, Charlotte, NC.
  • Krag DN; Department of Surgery and University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT.
  • Shukla GS; Department of Surgery and University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT Girja.Shukla@med.uvm.edu.
Ann Clin Lab Sci ; 52(3): 349-358, 2022 May.
Article en En | MEDLINE | ID: mdl-35777796
Asunto(s)
Palabras clave
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos / Neuroblastoma Tipo de estudio: Guideline Límite: Animals / Humans Idioma: En Revista: Ann Clin Lab Sci Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos / Neuroblastoma Tipo de estudio: Guideline Límite: Animals / Humans Idioma: En Revista: Ann Clin Lab Sci Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos